Prior Authorizations for Migraine Medications: Patient Tips
You finally got a prescription for a newer migraine medication. You take it to the pharmacy, and instead of a bag with your name on it you get a sentence that stops the whole thing: this needs prior authorization.
It's one of the most demoralizing moments in migraine care. You've already waited weeks for the appointment. You've already explained your attacks to a doctor who agreed you need something better. And now an insurer you've never spoken to is deciding whether you get it.
Prior authorization is common with the newer migraine medications, and while you can't remove the hurdle, you can make it clear a lot faster if you understand what's actually happening on the other end.
What prior authorization actually is
Prior authorization (often shortened to PA) is a requirement that your insurer approve a specific medication before it will pay for it. Your prescriber submits clinical information, the insurer reviews it against its own criteria, and it comes back approved or denied.
Two things are worth understanding up front.
First, a PA requirement isn't a judgment about whether the drug is right for you. It's a cost-control step applied to a whole category of medications, triggered automatically by the drug name, not by anything about your case.
Second, the decision is made against a written policy. Somewhere there is a document listing exactly what the insurer wants to see before it says yes. That document is the whole game — the requests that get approved are the ones that answer it point by point.
Why migraine drugs get flagged so often
Migraine care ran into a wave of genuinely new medications over the past decade — CGRP monoclonal antibodies, gepants, ditans, plus long-established options like Botox for chronic migraine. They work well for many people who failed older drugs. They're also expensive relative to the generic medications that came before them.
That combination is exactly what triggers prior authorization. Insurers generally want to see that cheaper options were tried first, a practice called step therapy. For migraine, that usually means they want documentation that you've tried and not tolerated, or not responded to, some number of older preventives — commonly drugs from the beta-blocker, antidepressant, or anti-seizure categories — before they'll cover a newer one.
The frustrating part is that "you tried it years ago" only counts if someone wrote it down somewhere the insurer can see.
The single most useful thing you can do
Keep your own treatment history, and bring it to the appointment where the new prescription gets written.
Your prescriber's notes may be incomplete — especially if you've changed doctors, moved, or tried medications through a different practice. Insurers don't accept "the patient says she tried it." They want dates, doses, and outcomes. If your record is thin, the PA gets denied on documentation grounds even when you genuinely meet the criteria.
A usable history looks like this for every migraine medication you've been on:
- Drug name and whether it was for prevention or for treating an attack
- Dose you reached, and how long you stayed on it
- Roughly when you took it — month and year is usually enough
- Why you stopped — no benefit, partial benefit, side effects (name them), cost
That last column matters more than people expect. "Didn't work" and "caused side effects I couldn't tolerate" are different criteria in most insurer policies, and both count as a completed trial.
Attack frequency is the other number they want
Most migraine PA criteria hinge on how many headache days you have per month. The line between episodic and chronic migraine sits at 15 or more headache days a month for longer than three months, with at least eight of those having migraine features — and coverage rules lean on that definition heavily. Botox for migraine, for instance, is generally approved only for chronic migraine. The three-month clause matters here: a single bad month usually won't satisfy a reviewer, which is another reason a continuous record beats a recent impression.
If you're asked how often you get migraines and you answer "a lot" or "most weeks," that's not a number anyone can submit. An actual count from an actual log is.
This is where a tracking habit pays off in a way that has nothing to do with your symptoms. A dated record of attacks — how many, how long, how disabling — turns a vague description into the exact data point the reviewer is looking for.
Working the process
Ask what's needed, specifically. Call your insurer's member services line and ask for the coverage criteria for the drug you were prescribed. You're entitled to know what the requirements are. Many plans publish these policies online too. Write down what they tell you and pass it to your prescriber's office.
Find out who handles PAs at your clinic. In most practices it isn't the doctor — it's a nurse, a medical assistant, or a dedicated prior authorization coordinator. Get that person's name. Your follow-up calls should go to them, not into the general appointment line.
Follow up on a schedule. Requests genuinely do get lost, sit in queues, or bounce back for a missing field. Call after a few business days and ask for the status and the reference number. Politely, persistently, on a schedule.
Ask about a peer-to-peer review if it's denied. This is a direct conversation between your prescriber and a physician at the insurer. It's often the fastest route to reversing a denial, because it lets your doctor explain the clinical picture that didn't fit the form's checkboxes.
If it gets denied
A denial is not the end of the process, and a meaningful share of appealed denials get overturned. Two things to do immediately.
Get the denial in writing and read the stated reason. It's usually specific — a missing trial of a particular drug class, insufficient documentation of frequency, a diagnosis code that doesn't match the criteria. Sometimes it's something as fixable as a form field left blank.
Then ask your prescriber's office to file an appeal. You have a right to appeal, there are deadlines involved so don't sit on it, and if internal appeals fail, most plans are subject to an external review by an independent reviewer.
Two other angles worth knowing: manufacturers of most branded migraine drugs run patient assistance or copay programs, and some will provide a bridge supply while a PA is pending. And if a specific drug proves genuinely unobtainable, ask your prescriber whether a different medication in the same class has easier coverage on your plan — formularies vary, and sometimes the sister drug sails through.
Where Pressure Pal fits
The evidence an insurer wants is mostly a counting problem, and counting from memory doesn't work. People consistently underestimate their headache days when asked to recall them, which means the number you give off the top of your head is probably lower than your real one.
Pressure Pal logs each attack with its date, duration, and severity, so when someone asks how many headache days you had last month, you have a real figure rather than an impression. It also tracks barometric pressure alongside your attacks, which adds a documented trigger pattern to the picture — useful for the clinical narrative your prescriber is building, and useful to you regardless of what the insurer decides.
That record does the same work in a peer-to-peer review or an appeal. Concrete, dated, patient-recorded data is harder to wave away than a general description of frequent headaches.
Bottom line
Prior authorization for migraine medication is a documentation contest, not a medical debate. The people who get through it fastest are the ones who arrive with a written treatment history, a real count of monthly headache days, and the patience to follow up until someone gives them an answer. None of it is fair — but all of it is workable, and a denial is a step in the process rather than the end of it.
This article is for general education and isn't a substitute for professional care or insurance advice. Coverage rules vary by plan and by country. Talk to your prescriber and your insurer about your specific situation.